Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage figure reported is based upon 958,504,891 shares of common stock outstanding, composed of: (i) 953,788,119 shares of common stock outstanding as of November 18, 2025, as reported in the Issuer's Form 424B5, filed with the SEC on November 21, 2025, (ii) 4,216,597 shares of common stock issuable upon exercise of warrants, and (iii) 500,175 shares of common stock issuable upon exercise of warrants deliverable upon exercise of listed call options.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage figure reported is based upon 958,504,891 shares of common stock outstanding, composed of: (i) 953,788,119 shares of common stock outstanding as of November 18, 2025, as reported in the Issuer's Form 424B5, filed with the SEC on November 21, 2025, (ii) 4,216,597 shares of common stock issuable upon exercise of warrants, and (iii) 500,175 shares of common stock issuable upon exercise of warrants deliverable upon exercise of listed call options.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage figure reported is based upon 957,776,189 shares of common stock outstanding, composed of: (i) 953,788,119 shares of common stock outstanding as of November 18, 2025, as reported in the Issuer's Form 424B5, filed with the SEC on November 21, 2025, (ii) 3,487,895 shares of common stock issuable upon exercise of warrants, and (iii) 500,175 shares of common stock issuable upon exercise of warrants deliverable upon exercise of listed call options.


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage figure reported is based upon 958,504,891 shares of common stock outstanding, composed of: (i) 953,788,119 shares of common stock outstanding as of November 18, 2025, as reported in the Issuer's Form 424B5, filed with the SEC on November 21, 2025, (ii) 4,216,597 shares of common stock issuable upon exercise of warrants, and (iii) 500,175 shares of common stock issuable upon exercise of warrants deliverable upon exercise of listed call options.


SCHEDULE 13G



 
D. E. Shaw & Co., L.P.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Chief Compliance Officer
Date:02/17/2026
 
D. E. Shaw & Co., L.L.C.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Authorized Signatory
Date:02/17/2026
 
D. E. Shaw Valence Portfolios, L.L.C.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Authorized Signatory
Date:02/17/2026
 
David E. Shaw
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Attorney-in-Fact for David E. Shaw
Date:02/17/2026

Comments accompanying signature:  Exhibit 1: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024. Exhibit 2: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co. II, Inc., in favor of the signatories hereto, among others, dated August 1, 2024.
Exhibit Information

Exhibit 3: Joint Filing Agreement, by and among the Reporting Persons, dated February 17, 2026.